PPB - Services

Complaints, Feedback and Enquiry

Safety Updates and Recommendations for Healthcare Professionals on Anti-Tuberculosis Medication (1 of 2022/2023)

[featured_image]
  • Version
  • Download 619
  • File Size 286.20 KB
  • File Count 1
  • Create Date March 20, 2023
  • Last Updated March 20, 2023

Safety Updates and Recommendations for Healthcare Professionals on Anti-Tuberculosis Medication (1 of 2022/2023)

Through one of its committees, the Pharmacovigilance Experts Review and Advisory Committee (PERAC), the Pharmacovigilance division conducted a causality assessment of the serious cases suspected to have been caused by some anti-tuberculosis medicines received at the Board and wishes to make recommendations for healthcare professionals on Anti-Tuberculosis Medication.

Attached Files

FileAction
SAFETY_UPDATE_1_0f_2022-2023.pdfDownload

Author

ppb_admin

Leave a comment

Your email address will not be published. Required fields are marked *